Generating HPV antigen-specific cells from a naive T cell population
US11999967B2 · kind B2 · utility
0Cited by
0References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 2021 |
| Grant date | Jun 4, 2024 |
| Priority date | — |
| Expiry date | Jun 5, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2502/1157
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Safe, rapid and efficient methods for producing antigen-specific T cells recognizing human papilloma virus or HPV antigens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.